RCEL insider buying and SEC filings, explained
AVITA Medical, Inc. · CIK 1762303
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq, OTC
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Avita Therapeutics, Inc.; Avita Medical, Ltd.
Insider activity in the last 12 months
Bought
$201K
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 12, 2026 | Purchase (code P) Amended filing | David D O'Toole (CFO) bought 2,000 shares at $3.97 ($8K), reported as a purchase (code P). Holdings up 1% to 152,927 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Jun 12. | SEC filing Filed Aug 24, 2026 |
| Jun 9, 2026 | Purchase (code P) | Joseph Fralin Woody (Director) bought 5,200 shares at $4.00 ($21K), reported as a purchase (code P). Holdings up 5% to 107,961 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 10, 2026 |
| Jun 9, 2026 | Purchase (code P) | Joseph Fralin Woody (Director) bought 10,000 shares at about $4.19 ($42K), reported as a purchase (code P). Holdings up 11% to 102,761 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 9, 2026 |
| Jun 3, 2026 | Purchase (code P) | Joseph Fralin Woody (Director) bought 10,000 shares at about $4.10 ($41K), reported as a purchase (code P). Holdings up 12% to 92,761 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 5, 2026 |
| Jun 1–2, 2026 | Purchase (code P) | Joseph Fralin Woody (Director) bought 20,000 shares between Jun 1 and Jun 2 at about $4.25 ($85K), reported as a purchase (code P). New position of 20,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| May 20, 2026 | Purchase (code P) | David D O'Toole (CFO) bought 2,000 shares at $4.26 ($9K), reported as a purchase (code P). Holdings up 1% to 145,927 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 20, 2026 |
| May 19, 2026 | Purchase (code P) | David D O'Toole (CFO) bought 2,000 shares at $4.24 ($8K), reported as a purchase (code P). Holdings up 1% to 143,927 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| Mar 11, 2026 | Purchase (code P) | David D O'Toole (CFO) bought 1,800 shares at $4.78 ($9K), reported as a purchase (code P). Holdings up 1% to 141,927 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 11, 2026 |
| Feb 19, 2026 | Purchase (code P) | David D O'Toole (CFO) bought 3,000 shares at $4.15 ($12K), reported as a purchase (code P). Holdings up 2% to 140,127 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
11 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 4:32 PM ET 8-K | Reg FD disclosure (Item 7.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RCEL in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.